Moderna and Merck mRNA cancer vaccine shows success in Phase 3 melanoma trial

·1 views

Moderna and Merck have announced positive results from a Phase 3 clinical trial of their mRNA-based cancer vaccine targeting melanoma. The vaccine demonstrated effectiveness in preventing the recurrence and spread of the cancer. This marks a significant milestone in the development of personalized mRNA cancer therapies, building on the same technology platform used in COVID-19 vaccines. The trial's success brings the experimental treatment closer to potential regulatory approval and broader clinical use.

Read the full story at Ars Technica

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Consumer Wariness Toward AI Grows Even as Adoption Rises

Despite artificial intelligence becoming increasingly prevalent in everyday life, consumer trust in the technology has not kept pace with its spread. Silicon Valley had anticipated that wider exposure to AI would naturally build public acceptance, but that assumption is proving incorrect. Users are becoming more cautious rather than more comfortable as AI becomes harder to avoid. The gap between adoption and genuine acceptance presents a significant challenge for the tech industry going forward.

0 comments Read more at TechCrunch

TechnologyTechCrunch ·

Google adds AI-powered study tools to Search and Gemini assistant

Google has rolled out a new set of AI-driven study features across its Search platform and Gemini assistant. The additions are designed to help students learn and study more effectively using AI support. The move reflects Google's ongoing strategy to position Gemini as the go-to AI assistant for academic use. Google faces stiff competition in this space from rivals such as OpenAI, which also targets student users with its own AI tools.

0 comments Read more at TechCrunch

TechnologyThe Verge ·

Google Gemini Launches Student Hub With Flashcards, Quizzes, and Deep Research

Google is introducing a dedicated student hub within its Gemini AI assistant ahead of the back-to-school season. The hub serves as a centralized space where students can collect research, create flashcards, take practice quizzes, and manage study notes. Study notebooks are also being upgraded to support graphs and images, and Gemini can automatically add test dates and deadlines to Google Calendar from a syllabus. Additionally, Google is integrating Deep Research into Gemini Live, allowing users to generate detailed research reports and discuss findings conversationally. Users can close the chat or lock their screen while a report is being generated, with Gemini notifying them upon completion.

0 comments Read more at The Verge

TechnologyTechCrunch ·

OpenAI Cuts Access for Researchers in Restricted Cybersecurity Program

Several cybersecurity researchers have reported losing access to OpenAI's Trusted Access for Cyber (TAC) program without prior notice. The TAC program is designed for vetted users and provides access to AI models with reduced safety restrictions for legitimate security research. Researchers described the revocation as sudden and unexpected. The program was created to allow qualified professionals to explore AI capabilities in cybersecurity contexts. OpenAI has not publicly explained the reasons behind the access removals.

0 comments Read more at TechCrunch